Show simple item record

dc.contributor.authorSalehi, Bahare
dc.contributor.authorSegura Carretero, Antonio 
dc.date.accessioned2021-05-28T12:12:29Z
dc.date.available2021-05-28T12:12:29Z
dc.date.issued2021-04-26
dc.identifier.citationSalehi B, Quispe C, Imran M, Ul-Haq I, Zˇ ivkovic´ J, Abu-Reidah IM, Sen S, Taheri Y, Acharya K, Azadi H, del Mar Contreras M, Segura-Carretero A, Mnayer D, Sethi G, Martorell M, Abdull Razis AF, Sunusi U, Kamal RM, Rasul Suleria HA and Sharifi-Rad J (2021) Nigella Plants – Traditional Uses, Bioactive Phytoconstituents, Preclinical and Clinical Studies. Front. Pharmacol. 12:625386. doi: [10.3389/fphar.2021.625386]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/68861
dc.descriptionM. d. M. Contreras thanks the FEDER UJA project 1260905 funded by "Programa Operativo FEDER 2014-2020" and "Consejeria de Economia y Conocimiento de la Junta de Andalucia". This work was also supported by CONICYT PIA/APOYO CCTE AFB170007.es_ES
dc.description.abstractNigella is a small genus of the family Ranunculaceae, which includes some popular species due to their culinary and medicinal properties, especially in Eastern Europe, Middle East, Western, and Central Asia. Therefore, this review covers the traditional uses and phytochemical composition of Nigella and, in particular, Nigella sativa. The pharmacological studies reported in vitro, in vivo, and in humans have also been reviewed. One of the main strength of the use of Nigella is that the seeds are rich in the omega-6 fatty acid linoleic acid and provide an extra-source of dietary phytochemicals, including the bioactive thymoquinone, and characteristics saponins, alkaloids, and flavonoids. Among Nigella species, N. sativa L. is the most studied plant from the genus. Due to the phytochemical composition and pharmacological properties, the seed and seed oil from this plant can be considered as good candidates to formulate functional ingredients on the basis of folklore and scientific knowledge. Nonetheless, the main limations are that more studies, especially, clinical trials are required to standardize the results, e.g. to establish active molecules, dosage, chemical profile, long-term effects and impact of cooking/incorporation into foods.es_ES
dc.description.sponsorshipPrograma Operativo FEDER 2014-2020 1260905es_ES
dc.description.sponsorshipJunta de Andalucia 1260905es_ES
dc.description.sponsorshipCONICYT PIA/APOYO CCTE AFB170007es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Research Foundationes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectNigellaes_ES
dc.subjectCancer es_ES
dc.subjectPharmacological propertieses_ES
dc.subjectFunctional ingredientses_ES
dc.subjectMetabolic syndromees_ES
dc.subjectThymoquinonees_ES
dc.titleNigella Plants – Traditional Uses, Bioactive Phytoconstituents, Preclinical and Clinical Studieses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3389/fphar.2021.625386
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España